Crucially, administration of the STING inhibitor H151 alleviates pathological myocardial hypertrophy, however its use diminishes the therapeutic effect of Tec.<h4>Conclusion</h4>Our findings confirmed that Tec may represent a promising lead compound targeting STING for pathological cardiac hypertrophy. Here, STING1 is linked to cardiac hypertrophy.